Isolated hyperthyroidism (i.e., without subsequent hypothyroidism) presented later than biphasic thyroiditis and primary hypothyroidism, and was associated with anti-PD-1 and anti-PDL1 inhibitors (avelumab, pembrolizumab and durvalumab) but not with combination therapy. Here, CD274 is linked to hyperthyroidism.